169 related articles for article (PubMed ID: 8294404)
1. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.
Sweeney HL; Straceski AJ; Leinwand LA; Tikunov BA; Faust L
J Biol Chem; 1994 Jan; 269(3):1603-5. PubMed ID: 8294404
[TBL] [Abstract][Full Text] [Related]
2. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
Eldin P; Le Cunff M; Mornet D; Leger JJ
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.
Sata M; Ikebe M
J Clin Invest; 1996 Dec; 98(12):2866-73. PubMed ID: 8981935
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
5. The possible role of myosin A1 light chain in the weakening of actin-myosin interaction.
Stepkowski D; Efimova N; Paczyņska A; Moczarska A; Nieznańska H; Kakol I
Biochim Biophys Acta; 1997 Jun; 1340(1):105-14. PubMed ID: 9217020
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
[TBL] [Abstract][Full Text] [Related]
7. A conserved negatively charged amino acid modulates function in human nonmuscle myosin IIA.
Wang F; Harvey EV; Conti MA; Wei D; Sellers JR
Biochemistry; 2000 May; 39(18):5555-60. PubMed ID: 10820029
[TBL] [Abstract][Full Text] [Related]
8. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.
Rayment I; Holden HM; Sellers JR; Fananapazir L; Epstein ND
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3864-8. PubMed ID: 7731997
[TBL] [Abstract][Full Text] [Related]
9. Interaction of F-actin with synthetic peptides spanning the loop region of human cardiac beta-myosin heavy chain containing Arg403.
Bartegi A; Roustan C; Chavanieu A; Kassab R; Fattoum A
Eur J Biochem; 1997 Dec; 250(2):484-91. PubMed ID: 9428702
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation and its effects on ATPase activity of cardiac and skeletal myosins.
Reddy YS; Wyborny LE
Tex Rep Biol Med; 1979; 39():79-90. PubMed ID: 162248
[TBL] [Abstract][Full Text] [Related]
11. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O; Leinwand LA
Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
[TBL] [Abstract][Full Text] [Related]
14. Structural and enzymatic comparison of human cardiac muscle myosins isolated from infants, adults, and patients with hypertrophic cardiomyopathy.
Schier JJ; Adelstein RS
J Clin Invest; 1982 Apr; 69(4):816-25. PubMed ID: 6210710
[TBL] [Abstract][Full Text] [Related]
15. Filament formation and actin-activated ATPase activity are abolished by proteolytic removal of a small peptide from the tip of the tail of the heavy chain of Acanthamoeba myosin II.
Kuznicki J; Côté GP; Bowers B; Korn ED
J Biol Chem; 1985 Feb; 260(3):1967-72. PubMed ID: 3155741
[TBL] [Abstract][Full Text] [Related]
16. Roles of the amino acid side chains in the actin-binding S-site of myosin heavy chain.
Eto M; Suzuki R; Morita F; Kuwayama H; Nishi N; Tokura S
J Biochem; 1990 Sep; 108(3):499-504. PubMed ID: 2148938
[TBL] [Abstract][Full Text] [Related]
17. M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments.
Teng GZ; Shaikh Z; Liu H; Dawson JF
Biochem Biophys Res Commun; 2019 Oct; 519(1):148-152. PubMed ID: 31481237
[TBL] [Abstract][Full Text] [Related]
18. Familial hypertrophic cardiomyopathic myosin mutations that affect the actin-myosin interaction.
Roopnarine O
Results Probl Cell Differ; 2002; 36():75-86. PubMed ID: 11892286
[No Abstract] [Full Text] [Related]
19. The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac β-myosin.
Bloemink M; Deacon J; Langer S; Vera C; Combs A; Leinwand L; Geeves MA
J Biol Chem; 2014 Feb; 289(8):5158-67. PubMed ID: 24344137
[TBL] [Abstract][Full Text] [Related]
20. Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains.
Yampolskaya DS; Kopylova GV; Shchepkin DV; Bershitsky SY; Matyushenko AM; Levitsky DI
Biochemistry (Mosc); 2022 Nov; 87(11):1260-1267. PubMed ID: 36509720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
